What is the IVF success rate for women over 40 in Hong Kong? Real data and clinical assessment for advanced maternal age

Opening scene: Doctor's decision-making logic (random selection)

A 43-year-old woman walks into the consultation room, holding a report showing an AMH level of 0.6 ng/mL. Her first question is, "Doctor, at my age, what are my chances of having a baby through IVF in Hong Kong?" Behind this question lie multiple variables including egg quality, embryo chromosomes, laboratory conditions, and individualized treatment plans. The following analysis breaks down the answer from two dimensions: clinical assessment and real-world data.

IVF Success Rate for Women Over 40: Age-Stratified Data

According to the annual reports of the Hong Kong Council on Human Reproductive Technology (HTA) and clinical statistics from multiple licensed IVF fertility centers, the live birth rate for women over 40 using their own eggs for IVF treatment shows a clear age-related decline. The data below presents the live birth rate range per embryo transfer cycle (the probability of having a live baby after a single transfer) and the cumulative live birth rate (the overall probability after completing 3 egg retrieval cycles).

Note: Data compiled from public HTA statistics and clinical reports from multiple fertility centers in Hong Kong. Individual results vary significantly; a single cycle outcome does not represent the final prognosis.

Why Does Age Have Such a Drastic Impact on Success Rates?

The core reason is that the chromosomal aneuploidy rate in eggs increases exponentially with age. At age 40, the chromosomal abnormality rate in eggs is about 60%; at 42, it rises to about 80%; and over 45, it exceeds 90%. Embryos with chromosomal abnormalities either fail to implant, result in early miscarriage, or very rarely develop into a healthy live baby.

Furthermore, ovarian reserve (measured by AMH, FSH, and antral follicle count) declines with age, reducing the number of eggs that can be retrieved, which further decreases the probability of obtaining a euploid embryo. Even if multiple eggs are obtained through ovarian stimulation, the number that can form transferable embryos remains limited.

When is it unsuitable to continue using one's own eggs? — When AMH is below 0.4 ng/mL, no transferable embryos are obtained after two consecutive cycles, or embryo chromosomal testing consistently shows abnormalities. In such cases, egg donation should be considered.

How Do Doctors Assess Individual Prognosis for Older Patients?

When consulting with patients over 40, reproductive specialists do not base their conclusions solely on age. Instead, they systematically evaluate the following indicators:

• Basal Endocrine Profile: FSH, LH, E2 (measured on day 2–3 of the menstrual cycle). FSH >12 IU/L may indicate diminished ovarian response.
• AMH and Antral Follicle Count: AMH ≥1.0 ng/mL and AFC ≥7 usually indicate a sufficient number of eggs can be obtained; AMH <0.5 ng/mL suggests difficulty in egg retrieval.
• Chromosomal and Genetic Screening: Karyotyping for both partners; additional evaluation is needed for carriers of balanced chromosomal translocations.
• Uterine Environment: Hysteroscopy to rule out endometrial polyps, adhesions, and chronic endometritis.
• Metabolic and Immune Factors: Thyroid function, vitamin D levels, blood glucose and insulin resistance, autoantibodies, etc.

The focus of assessment varies by age group:

• 40–41 years: Main focus is on ovarian reserve and sperm quality. Most patients can obtain a sufficient number of embryos. PGT-A screening can improve the efficiency of a single transfer.
• 42–43 years: The embryo chromosomal abnormality rate is already high. Doctors will focus on discussing the necessity of PGT-A and whether multiple cycles are needed to accumulate euploid embryos.
• 44–45 years: The availability of viable own eggs decreases. Doctors will simultaneously prepare an egg donation backup plan to prevent patients from experiencing physical and mental exhaustion from repeated failures.
• Over 45 years: Clinical guidelines recommend prioritizing the evaluation of the egg donation pathway. IVF with own eggs is not the first-line recommendation.

Easily Overlooked Details: Endometrium, Metabolism, and Embryo Culture Environment

Older patients often focus all their attention on the eggs, but the following factors also significantly impact the final live birth outcome:

• Chronic Endometritis: Occurs in about 30–40% of infertile women. Older women are more susceptible due to decreased endometrial receptivity. Diagnosis is made via hysteroscopy and endometrial biopsy with CD138 staining. Prognosis can improve after antibiotic treatment.
• Vitamin D Deficiency: Vitamin D receptors are widely expressed in the endometrium. Deficiency can reduce implantation rates. It is recommended to maintain serum 25-OH-D levels above 40 ng/mL.
• Subclinical Thyroid Dysfunction: Even TSH levels between 2.5–4.0 mIU/L may adversely affect implantation. For older women, it is recommended to keep TSH below 2.5.
• Embryo Culture Conditions: The culture system of different laboratories (time-lapse imaging, low oxygen culture, sequential media) significantly affects the developmental potential of embryos from older women. Choosing a laboratory with experience in handling embryos from advanced maternal age is crucial.

Common Pitfalls: Cognitive Misconceptions and Decision-Making Blind Spots

The following misconceptions are common in clinical practice and may lead patients down the wrong path or cause unnecessary failures:

• Blindly Pursuing Follicle Quantity: Ovarian reserve is limited in older patients. Overusing high doses of stimulation medications does not increase the number of euploid embryos and may actually reduce egg quality. Doctors should choose mild stimulation or natural cycle protocols based on AFC and AMH.
• Ignoring Embryo Chromosomal Screening: For patients over 43, directly transferring embryos without PGT-A screening can result in a miscarriage rate exceeding 50%, and the psychological burden after repeated failures is immense.
• Frequently Changing Fertility Centers: Each center has its own laboratory system and clinical protocols. Frequently switching prevents doctors from systematically accumulating a patient's cycle data, thus delaying progress.
• Over-reliance on "Tuning" the Body, Delaying Treatment: Ovarian function in older women declines month by month. Spending months on supplements or traditional Chinese medicine may miss the optimal treatment window.
• Holding Prejudices Against Egg Donation: When it is essentially impossible to obtain a euploid embryo from one's own eggs, egg donation is a medically reasonable choice. Procrastination or avoidance only increases time costs and emotional drain.

How to know if you are falling into these pitfalls? — If you fail to obtain a transferable embryo after two consecutive stimulation cycles, or if all transfers result in miscarriage, you should pause and undergo a comprehensive re-evaluation of both partners, rather than blindly starting the next cycle.

Interpretation of Key Examination Indicators: AMH, FSH, AFC, and Chromosomes

The following indicators are core tools for assessing IVF prognosis in patients over 40. Doctors interpret them comprehensively rather than in isolation:

What is the specific process? — On day 2–3 of the menstrual cycle, blood is drawn to check FSH, LH, E2, and AMH, and a vaginal ultrasound is performed to count antral follicles. Chromosomal karyotyping can be done at any time and does not require fasting. PGT-A requires a biopsy when the embryo reaches the blastocyst stage, which takes about 5–6 days.

Frequently Asked Questions: Top 5 Concerns of Patients

Q1: What tests are needed for IVF over 40?

Required tests include: AMH, FSH, LH, E2, thyroid function, vitamin D, hysteroscopy, chromosomal karyotyping, and semen analysis (for the male partner). The general process is: initial consultation → basal endocrine tests → ovarian reserve assessment → uterine cavity evaluation → formulation of a stimulation protocol. How long does it take? — It usually takes 2–4 weeks from the initial consultation to starting the cycle to complete all tests.

Q2: Can I still do IVF if my AMH is low?

Yes. A low AMH level simply indicates that the number of eggs retrieved may be low, but it does not mean there is no chance. Based on the AMH value, the doctor will choose a protocol such as mild stimulation, natural cycle, or gentle stimulation, aiming for high-quality eggs rather than quantity. If AMH is <0.4 ng/mL and age is ≥43, the possibility of egg donation should be discussed in advance.

Q3: Is PGT-A screening really necessary?

For women over 40, PGT-A screening can significantly reduce the miscarriage rate and improve the efficiency of a single transfer. Without PGT-A, directly transferring embryos based on morphological grading increases the probability of selecting a chromosomally abnormal embryo as age increases. When is it suitable? — Whenever there are ≥2 blastocysts available for biopsy, it is recommended. When is it unsuitable? — When the number of embryos is very low (only 1) and the biopsy risk might affect the embryo's survival; this requires careful discussion with the doctor.

Q4: What should I do after multiple failed transfers?

A systematic investigation is needed: ① Endometrial receptivity (ERA test, chronic endometritis); ② Embryo chromosomes (retrospective PGT-A on previously transferred embryos, or PGT-A in a new cycle); ③ Immune and coagulation factors (antiphospholipid antibodies, NK cell activity, thrombophilia); ④ Uterine anatomical abnormalities (repeat hysteroscopy). It is not recommended to blindly start the next cycle without identifying the cause.

Q5: Does Hong Kong have advantages for older women undergoing IVF compared to Mainland China?

Hong Kong's advantages include: ① Strict laboratory quality management system (regulated by HTA) with high data transparency; ② Legal availability of PGT-A and egg donation; ③ Alignment with international advanced protocols, particularly rich experience in individualized stimulation and embryo culture for older women. However, costs are relatively higher, and arrangements for Hong Kong and Macau entry permits and visas are needed, requiring advance planning.

Clinician's Observations: Several Phenomena in Real Clinical Practice

As a reproductive specialist who frequently treats older patients, here are a few observations for reference:

• The impact of mindset on outcomes is underestimated: Under the same medical conditions, patients who are emotionally stable and have reasonable expectations for treatment show higher compliance and ultimately higher live birth rates. Anxiety may affect endometrial receptivity through hormones like cortisol.
• Male age is equally important: For women over 40, if the partner is over 45, elevated sperm DNA fragmentation can also affect embryo development and implantation. Concurrent evaluation of the male partner is necessary.
• Do not overlook previous pregnancy history: Patients who have had a natural pregnancy (even if it ended in miscarriage) generally have a better prognosis than older women with primary infertility, as it at least proves the functional reproductive pathway.
• Egg donation is not a "failure" marker: When it is impossible to obtain a euploid embryo from one's own eggs, egg donation is the most direct and effective medical path. The live birth rate for patients receiving egg donation can return to levels seen in women under 35 (single-cycle live birth rate about 45–55%).

This content is compiled based on general knowledge in the assisted reproductive technology field and clinical practice in Hong Kong. It aims to provide objective medical reference and does not constitute personal medical advice. Please consult a qualified reproductive medicine center for specific diagnosis and treatment plans.